30 Participants Needed

AI Technology for Depression and Anxiety Detection

AM
Overseen ByAndie M Moore, MS
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Kiran Faryar, MD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

Behavioral health problems, such as depression and anxiety, are common yet often are not identified by emergency department doctors and nurses. These mental health conditions can be due to medical issues or can worsen medical problems. One way investigators hope to do a better job of learning about mental health is by training Artificial Intelligence (AI) software to detect anxiety and depression by analyzing facial expression and tone of voice. Participants are invited to participate in a study which may help improve emergency department care. An audio and video recording of the participant's responses to some simple, non-psychological questions will be analyzed by a computer to determine whether investigators can assess mood and anxiety by analyzing speech and visual patterns. The audio and video will not be listened to nor watched by study personnel, only analyzed by a computer. The investigator's hope is that it will help others in the future by aiding in the assessment of psychological state. This study is being conducted at CMC ED only.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Biometrics for depression and anxiety detection?

Research shows that wearable AI technology using motor activity data can effectively predict depression levels, suggesting that similar biometric data could help in identifying and managing depression and anxiety. Additionally, a digital biodata-driven program has shown promise in engaging users and managing symptoms of depression and anxiety.12345

Is AI technology for detecting depression and anxiety safe for humans?

The research does not provide specific safety data for AI technology used in detecting depression and anxiety, but it suggests that wearable AI is still in its early stages and should be used alongside other methods until further studies improve its performance.16789

How does AI technology for depression and anxiety detection differ from other treatments?

This AI technology is unique because it uses wearable devices and machine learning models to predict and identify depression and anxiety by analyzing physiological data like motor activity and cardiovascular signals, offering a non-invasive and potentially more accessible alternative to traditional psychiatric interviews.14101112

Research Team

KF

Kiran Faryar, MD, MPH

Principal Investigator

University Hospitals

Eligibility Criteria

This trial is for emergency department patients who may have depression or anxiety. It aims to test if AI can identify these conditions by analyzing facial expressions and tone of voice from recordings during their visit.

Inclusion Criteria

I am over 18 and went to the emergency department on my own without any clear mental health issues.
English-speaking
Patients with non-emergent concerns of Emergency Severity Index (ESI) level 3, 4, or 5

Exclusion Criteria

Prisoners
Patients who are deemed to be critically ill (including life or limb-threatening illness) or unable to consent
Non-English Speaking

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Assessment

Participants complete assessments and questionnaires, and are recorded reading a story to capture facial expressions and audio cues

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after assessment

2-4 weeks

Treatment Details

Interventions

  • Biometrics
Trial OverviewThe study tests an AI software's ability to detect signs of depression and anxiety through biometrics, using participants' audio and video responses to simple questions recorded in the emergency department.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Participants seen at University Hospitals Cleveland Medical Center Emergency DepartmentExperimental Treatment1 Intervention
Eligible patients must present with non-emergent concerns of Emergency Severity Index (ESI) level 3, 4, or 5. Patients will complete assessments and questionnaires and end with being recorded reading a story to capture facial expressions and audio cues.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Kiran Faryar, MD

Lead Sponsor

Trials
1
Recruited
30+

University Hospitals Cleveland Medical Center

Lead Sponsor

Trials
348
Recruited
394,000+

Findings from Research

The 16-week Feel Program, a digital mental health support initiative, showed a 65% retention rate among 48 adult participants, with high user satisfaction (65% reported very high satisfaction) and significant engagement in activities designed to manage depressive and anxiety symptoms.
Results indicated that 93.5% of participants experienced a decrease in depressive or anxiety symptoms, with 51.6% showing clinically significant improvement, suggesting that higher engagement in the program correlates with better mental health outcomes.
Feasibility, engagement, and preliminary clinical outcomes of a digital biodata-driven intervention for anxiety and depression.Tsirmpas, C., Andrikopoulos, D., Fatouros, P., et al.[2022]
The study developed machine learning models using Danish registry data from 1995 to 2018 to predict non-fatal suicide attempts and suicides after psychiatric discharge, achieving a high predictive accuracy for attempts (ROC-AUC of 0.85) and moderate accuracy for suicides (ROC-AUC of 0.71).
The results highlight the importance of treating suicide and non-fatal suicide attempts as separate outcomes, as the predictors for each differed, and the ensemble models showed fair performance across different sexes and ages, suggesting they could be more reliable for clinical use than simpler models.
Prediction models of suicide and non-fatal suicide attempt after discharge from a psychiatric inpatient stay: A machine learning approach on nationwide Danish registers.Nielsen, SD., Christensen, RHB., Madsen, T., et al.[2023]

References

Performance of Artificial Intelligence in Predicting Future Depression Levels. [2023]
Feasibility, engagement, and preliminary clinical outcomes of a digital biodata-driven intervention for anxiety and depression. [2022]
Proactive screening for depression through metaphorical and automatic text analysis. [2012]
Diagnosis of Depressive Disorder Model on Facial Expression Based on Fast R-CNN. [2022]
The project for objective measures using computational psychiatry technology (PROMPT): Rationale, design, and methodology. [2022]
Predictive modeling of depression and anxiety using electronic health records and a novel machine learning approach with artificial intelligence. [2021]
Systematic review and meta-analysis of performance of wearable artificial intelligence in detecting and predicting depression. [2023]
Classification of Suicide Attempts through a Machine Learning Algorithm Based on Multiple Systemic Psychiatric Scales. [2020]
Prediction models of suicide and non-fatal suicide attempt after discharge from a psychiatric inpatient stay: A machine learning approach on nationwide Danish registers. [2023]
Automated recognition of major depressive disorder from cardiovascular and respiratory physiological signals. [2023]
Computer assisted identification of stress, anxiety, depression (SAD) in students: A state-of-the-art review. [2023]
Deep Neural Networks for Depression Recognition Based on 2D and 3D Facial Expressions Under Emotional Stimulus Tasks. [2021]